The human pancreatic cancer cell lines MiaPaPc-2, BxPC-3 and PANC-1 were purchased from the American Type Culture Collection. The S2VP10 cells, derived from the Suit-2 cells as reported30 (link), were originally provided by Dr. M. Hollingsworth (University of Nebraska). Cell line authentication was determined by short tandem repeat analysis (STR) performed by the American Type Culture Collection. OGT overexpression MiaPaPc-2 and BxPC-3 cells were generated by transfection of pCMV-flag-OGT (OGT, Addgene, #29760); and OGT knockdown S2VP10 and PANC-1 cells were generated by infected with lentiviruses containing a short hairpin RNA (shRNA) specific for OGT (shOGT, Addgene, #10878). PANC-1 cells with FADD knockdown were established as we previously described by shRNA targeting FADD (Open Biosystems)31 (link). All stable clones were selected by 2 μg/ml puromycin as we previously reported31 (link). Sequencing analysis was performed to confirm the correct sequence, and protein expression was validated by Western blot analysis. Apoptosis was induced by TRA-8, a DR5 agonist antibody that was generated as previously described32 (link); and determined by Annexin V-fluorescein isothiocyanate (FITC) and propidium iodide (PI) staining kit (BD Biosciences, San Jose, CA) and analyzed by flow cytometry as we previously reported11 (link).